Transcranial Magnetic Stimulation (TMS)
A non-invasive procedure that uses focused magnetic pulses to induce electrical currents in a targeted region of cortex — most often the dorsolateral prefrontal cortex — modulating its activity. FDA-cleared for depression and OCD.
Benefits
Non-invasive and awake (no anesthesia), FDA-cleared for treatment-resistant depression and OCD, few systemic side effects, no cognitive impairment.
Risks
Scalp discomfort or headache, rare risk of seizure, transient hearing effects without earplugs; requires a course of daily sessions over weeks.
Informational only — not medical advice.
Neurotransmitters
Brain areas
Related
Research (8)
- Transcranial Magnetic Stimulation during Gait: A Review of Methodological and Technological Challenges V (2022) PubMed ↗
- Advances in transcranial magnetic stimulation (TMS) and its applications in resistant depression Koutsomitros et al. (2021) PubMed ↗
- Transcranial Magnetic Stimulation and the Understanding of Behavior Pitcher et al. (2021) PubMed ↗
- Noninvasive Transcranial Magnetic Brain Stimulation in Stroke Hernandez-Pavon et al. (2019) PubMed ↗
- Transcranial Magnetic Stimulation for Adolescent Depression Croarkin et al. (2019) PubMed ↗
- Transcranial Magnetic Stimulation in Conditions Other than Major Depressive Disorder Becker et al. (2019) PubMed ↗
- Transcranial magnetic stimulation: a primer Hallett (2007) PubMed ↗
- Transcranial magnetic stimulation Reid (2003) PubMed ↗
Community
Log in to rate and share your notes.
No contributions yet.